Beam Therapeutics Inc (NASDAQ:BEAM)
| 29.56 Delayed Data As of 3:59pm ET |  -0.01 / -0.03%Today’s Change | 16.95 Today|||52-Week Range 51.60 | -24.42% Year-to-Date |
Latest BEAM News | Press Releases
| You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. 8:30am / MotleyFool.com - Paid Partner Content | Wall Street Analysts Believe Beam Therapeutics Inc. (BEAM) Could Rally 81.29%: Here's is How to Trade Nov 30 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.57 |
| Today’s open | 29.46 |
| Day’s range | 28.33 - 30.27 |
| Volume | 61,931 |
| Average volume (3 months) | 1,163,802 |
| Market cap | $2.4B |
Data as of 3:59pm ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | +28.45% |
| Earnings growth (this year) | -34.01% |
| Earnings growth (next 5 years) | +9.19% |
| Revenue growth (last year) | +17.51% |
| P/E ratio | NM |
| Price/Sales | 44.95 |
| Price/Book | 2.85 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 27, 2024 |
| EPS forecast (this quarter) | -$1.44 |
| Annual revenue (last year) | $60.9M |
| Annual profit (last year) | -$289.1M |
| Net profit margin | -474.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
